Clinical trial
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
NCT01531790
Study timeline
Study start (unknown)2011-09-01Date precision: month
Registry last updated2013-01-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-Small Cell Lung Cancerunresolved
Interventions
CarboplatinDRUG · verified · RxNorm: carboplatin
PemetrexedDRUG · verified · RxNorm: pemetrexed
EndostarDRUG
CentrumDRUG
Sponsors & collaborators
Jiangsu Simcere Pharmaceutical Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01531790 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.